Ludwig Institute for Cancer Research
Brussels
Belgium
Papers:
F.105
INTERLEUKIN-22 IS A CRITICAL MEDIATOR OF VACCINE-INDUCED REDUCTION OF HELICOBACTER INFECTION IN THE MOUSE MODEL
T.75
IL-22BP is produced by EOSINOPHILS in HUMAN GUT and INHIBITS the PROTECTIVE ACTIONS of IL-22 during experimental COLITIS